Source:http://linkedlifedata.com/resource/pubmed/id/10532865
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
1999-10-20
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0031-4005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
993-4; author reply 995
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10532865-Antibodies, Monoclonal,
pubmed-meshheading:10532865-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:10532865-Humans,
pubmed-meshheading:10532865-Infant,
pubmed-meshheading:10532865-Injections, Intramuscular,
pubmed-meshheading:10532865-Pain,
pubmed-meshheading:10532865-Respiratory Syncytial Virus Infections
|
pubmed:year |
1999
|
pubmed:articleTitle |
IMpact-RSV Study Group report.
|
pubmed:publicationType |
Letter,
Comment
|